ArticleNature communications2021
A KRAS-responsive long non-coding RNA controls microRNA processing.
Open access · goldAbstract read
In one paragraph
Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.6field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 46 citations in OpenAlex.
- DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers.Journal of experimental & clinical cancer research : CR · 2026Review
- Therapeutic modulation of HIV-1 using miRNAs and lncRNAs: from bench to bedside.Virology journal · 2026Review
- Article
- The Role of Non-Coding Regions in Breast Cancer: From Gene Regulation to Therapeutic Implications.Pharmaceuticals (Basel, Switzerland) · 2025Review
- Chemically modified non-coding RNAs in cancer.Expert reviews in molecular medicine · 2025Review
- Emerging trends and hotspots in lung cancer-prediction models research.Annals of medicine and surgery (2012) · 2024Review
- Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.International journal of molecular sciences · 2024Review
- RNA expression of 6 genes from metastatic mucosal gastric cancer serves as the global prognostic marker for gastric cancer with functional validation.British journal of cancer · 2024Article
- Long Noncoding RNA VLDLR-AS1 Levels in Serum Correlate with Combat-Related Chronic Mild Traumatic Brain Injury and Depression Symptoms in US Veterans.International journal of molecular sciences · 2024Article
- Targeting ST8SIA6-AS1 counteracts KRASExperimental hematology & oncology · 2023Article
- p53-regulated lncRNAs in cancers: from proliferation and metastasis to therapy.Cancer gene therapy · 2023Review
- LncRNA RP11-58O9.2 predicts poor prognosis and promotes progression of non-small cell lung cancer.The Journal of international medical research · 2023Article
- Mutant KRAS Mediates circARFGEF2 Biogenesis to Promote Lymphatic Metastasis of Pancreatic Ductal Adenocarcinoma.Cancer research · 2023Article
- An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stress.Nature communications · 2023Article
- Long non‑coding RNAs as potential therapeutic targets in non‑small cell lung cancer (Review).International journal of molecular medicine · 2023Review
- Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer.Cell death and differentiation · 2023Article
- KRAS Hijacks the miRNA Regulatory Pathway in Cancer.Cancer research · 2023Article
- Article
- SDNOR, a Novel Antioxidative lncRNA, Is Essential for Maintaining the Normal State and Function of Porcine Follicular Granulosa Cells.Antioxidants (Basel, Switzerland) · 2023Article
- Absence of Scaffold Protein Tks4 Disrupts Several Signaling Pathways in Colon Cancer Cells.International journal of molecular sciences · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 5 institutions in 2 countries.
Lei ShiTranscriptional Networks in Lung Cancer Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.ORCID 0000-0003-4027-2396
Peter MageeTranscriptional Networks in Lung Cancer Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
Matteo FassanDepartment of Medicine, Surgical Pathology & Cytopathology Unit, University of Padua, Padua, Italy.ORCID 0000-0001-6515-5482
Sudhakar SahooComputational Biology Support, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
Hui Sun LeongComputational Biology Support, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
Dave LeeComputational Biology Support, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
Robert SellersComputational Biology Support, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
Laura Brullé-SoumaréXentech, 4 rue Pierre Fontaine, Evry, France.ORCID 0000-0003-3371-2496
Stefano CairoXentech, 4 rue Pierre Fontaine, Evry, France.ORCID 0000-0002-4725-5970
Tiziana MonteverdeTranscriptional Networks in Lung Cancer Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
Stefano VoliniaDepartment of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.
Duncan D SmithBiological Mass Spectrometry Facility, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
Gianpiero Di LevaSchool of Pharmacy and Bioengineering, Keele University, Stock-on-Trent, UK.
Francesca GaluppiniDepartment of Medicine, Surgical Pathology & Cytopathology Unit, University of Padua, Padua, Italy.
Athanasios R PaliourasTranscriptional Networks in Lung Cancer Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
Kang ZengImaging & Cytometry Facility, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
Raymond O'KeefeDivision of Evolution & Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.ORCID 0000-0001-8764-1289
Michela GarofaloTranscriptional Networks in Lung Cancer Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK. michelagarofalo1@gmail.com.ORCID 0000-0002-1741-0415
University of Manchester · GBCancer Research UK · GBUniversity of Padua · ITKeele University · GBUniversity of Ferrara · IT
Funding
Cancer Research UK C5759/A20465Cancer Research UK C5759/A20971
Abstract
Wild-type KRAS (KRAS
Indexed as
Gene Expression Regulation, NeoplasticA549 CellsAnimalsCarcinoma, Non-Small-Cell LungCell Line, TumorFemaleGene Expression ProfilingGene OntologyHumansKaplan-Meier EstimateLung NeoplasmsMiceMice, Inbred NODMice, KnockoutMice, SCIDMicroRNAsKRAS protein, humanMicroRNAsNPM1 protein, humanNpm1 protein, mouseNucleophosminProto-Oncogene Proteins p21(ras)RNA, Long Noncoding
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.